Morepen Labs’s annual FY22 revenue increases by 30 per cent
Consolidated Profit Before Tax (PBT) at Rs 126.70 crores has risen by 29 per cent in FY22 and Profit After Tax (PAT) at Rs 101.68…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Morepen Labs
Morepen gets US FDA approval for Fexofinadine
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
Morepen Labs Board approves medical devices business into a wholly-owned subsidiary
The company is engaged in pharmaceutical business comprising the manufacturing and sales of active pharmaceutical ingredients…
Morepen EGM approves Rs 433 crores investment from Corinth and promoters
Shareholders also approved 50 million fully convertible warrants a promoter group company Liquid Holdings at Rs 38 per warrant/…
Morepen Labs’ Net Profit rises by 256 per cent led by higher APIs exports
The company’s net sales revenue (standalone) in Q1 ’FY 2019-20 stood at Rs 186.70 crore showing a growth of 25.4 per cent…